(4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride has been researched along with Disease Models, Animal in 2 studies
(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride: A drug that selectively activates certain subclasses of muscarinic receptors and also activates postganglionic nicotinic receptors. It is commonly used experimentally to distinguish muscarinic receptor subtypes.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koga, K | 1 |
| Matsuzaki, Y | 1 |
| Honda, K | 1 |
| Eto, F | 1 |
| Furukawa, T | 1 |
| Migita, K | 1 |
| Irie, K | 1 |
| Mishima, K | 1 |
| Ueno, S | 1 |
| Lograsso, M | 1 |
| Nadeson, R | 1 |
| Goodchild, CS | 1 |
2 other studies available for (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride and Disease Models, Animal
| Article | Year |
|---|---|
Activations of muscarinic M
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Analgesics; Animals; Disease M | 2017 |
The spinal antinociceptive effects of cholinergic drugs in rats: receptor subtype specificity in different nociceptive tests.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Animals; Carbachol; Cholinergi | 2002 |